Martin Shkreli ‘pharma bro no more’, ordered to pay $64.6 million to price gouge victims, banned from drug industry


The Federal Trade Commission and seven states, including New York, sued in January 2020 accusing Vyera Pharmaceuticals — formerly Shkreli’s company Turing — of increasing the price of Daraprim by more than 4,000% from $ 17.50 to $ 750 a pill.

Read more here New York Daily News

Leave A Reply